``We also realize that some shareholders get frustrated when there is a gap for a period of time as to announcements of new license transactions for our patent portfolio,`` Pohl said. ``The Alliacense licensing team which manages our portfolio, which is jointly-owned and marketed as the Moore Microprocessor Patent(TM) (MMP) Portfolio, continues to diligently pursue negotiations with candidate companies. The nature of the process is such that it requires our patience because, as much as we and our shareholders might desire otherwise, the status and progress of negotiations must remain confidential, and license agreements are not consummated according to any regular or predictable schedule,`` he added. ``We remain optimistic about our outlook, and we remain focused on maximizing the long-term value of our business for the benefit of our shareholders,`` Pohl said.

Following this recent development Patriot Scientific Corporation traded down over 10.0%as investors continue to sell this company which only a short time ago traded at nearly $1.50. Currently trading at $0.92 this stock looks like it may continues this downwards momentum as investors wait to see what takes place at the shareholders meeting. The BWR Research Team will continue to follow the market sentiment on this company and numerous others.

Shows what little I know. I figured we would go up in anticipation of what was going to be presented at SHM. They think it will keep going down till we have the SHM.